DAILY VARIATIONS OF PLATELET-AGGREGATION IN RELATION TO BLOOD AND PLASMA SEROTONIN IN DIABETES

被引:86
作者
MALYSZKO, J
URANO, T
KNOFLER, R
TAMINATO, A
YOSHIMI, T
TAKADA, Y
TAKADA, A
机构
[1] HAMAMATSU UNIV SCH MED, DEPT PHYSIOL, HAMAMATSU, SHIZUOKA 43131, JAPAN
[2] HAMAMATSU UNIV SCH MED, DEPT INTERNAL MED 2, HAMAMATSU, SHIZUOKA 43131, JAPAN
关键词
DIABETES; PLATELET AGGREGATION; CIRCADIAN RHYTHM; SEROTONIN;
D O I
10.1016/0049-3848(94)90231-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The circadian rhythms of platelet aggregation in the whole blood and platelet rich plasma-PRP and plasma serotonin were studied in healthy volunteers (n=10) and diabetic patients (type II diabetes mellitus n=12). Platelet aggregation in the whole blood induced by collagen (2 mu g/ml), ADP (1O mu M), arachidonic acid (0.5 mM) and epinephrine (10 mu M), and in PRP induced by collagen (2 mu g/ml), ADP (5 mu M), arachidonic acid (250 mu M), epinephrine (1O mu M) and serotonin-5-HT (1 mu M) was measured at 7:30, 11:30, 17:00, 23:00, 4:00 and 7:00. In healthy subjects collagen- and ADP-induced platelet aggregation in the whole blood was significantly lower at 23:00 and 4:00 when compared to values at 7:30. In PRP normal and diabetic platelet response was the lowest during the night. Diabetic platelets exhibited an enhanced response to 5-HT starting from 17:00 until 4:00 when compared to 7:30. 5-HT-induced platelet aggregation was found to be significantly higher throughout the study in DM patients over controls in parallel to plasma 5-HT. In healthy volunteers plasma 5-HT was higher at 17:00 when compared to baseline values, whereas in DM patients plasma 5-HT was elevated starting from 17:00 until 4:00. An enhanced response of diabetic platelets to 5-HT together with elevated plasma 5-HT levels may contribute, at least partly, to the pathogenesis of diabetic vasculopathy and 5HT(2) receptor blockers may be of value in DM patients.
引用
收藏
页码:569 / 576
页数:8
相关论文
共 29 条
[1]  
ANDERSON GM, 1981, CLIN CHEM, V27, P775
[2]   INTRAPLATELET SEROTONIN IN PATIENTS WITH DIABETES-MELLITUS AND PERIPHERAL VASCULAR-DISEASE [J].
BARRADAS, MA ;
GILL, DS ;
FONSECA, VA ;
MIKHAILIDIS, DP ;
DANDONA, P .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1988, 18 (04) :399-404
[3]   PLATELET-FUNCTION IN DIABETES-MELLITUS IN RELATIONSHIP TO COMPLICATIONS, GLYCOSYLATED HEMOGLOBIN AND SERUM-LIPOPROTEINS [J].
BETTERIDGE, DJ ;
ZAHAVI, J ;
JONES, NAG ;
SHINE, B ;
KAKKAR, VV ;
GALTON, DJ .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1981, 11 (04) :273-277
[4]   AGGREGATION OF BLOOD PLATELETS BY ADENOSINE DIPHOSPHATE AND ITS REVERSAL [J].
BORN, GVR .
NATURE, 1962, 194 (4832) :927-&
[5]  
COHEN RA, 1985, SEROTONIN CARDIOVASC, P105
[6]   NEW CONCEPTS ABOUT THE PATHOGENESIS OF ATHEROSCLEROSIS IN DIABETES-MELLITUS [J].
COLWELL, JA ;
WINOCOUR, PD ;
LOPESVIRELLA, M ;
HALUSHKA, PV .
AMERICAN JOURNAL OF MEDICINE, 1983, 75 (5B) :67-80
[7]   PLATELET-AGGREGATION AND COAGULATION-FACTORS IN INSULIN-DEPENDENT DIABETICS WITH AND WITHOUT MICROANGIOPATHY [J].
DALLINGER, KJC ;
JENNINGS, PE ;
TOOP, MJ ;
GYDE, OHB ;
BARNETT, AH .
DIABETIC MEDICINE, 1987, 4 (01) :44-48
[8]  
DECLERCK F, 1982, 5 HYDROXYTRYPTAMINE
[9]  
EK J, 1982, SCAND J HAEMATOL, V29, P185
[10]   DAILY VARIATIONS IN PLATELET-AGGREGATION AND ADHESION IN HEALTHY-SUBJECTS [J].
FUJIMURA, A ;
OHASHI, K ;
EBIHARA, A .
LIFE SCIENCES, 1992, 50 (14) :1043-1047